The latest price target for Aemetis (NASDAQ:AMTX) was reported by HC Wainwright & Co. on November 15, 2024. The analyst firm set a price target for $28.00 expecting AMTX to rise to within 12 months (a possible 933.21% upside). 11 analyst firms have reported ratings in the last year.

The latest analyst rating for Aemetis (NASDAQ:AMTX) was provided by HC Wainwright & Co., and Aemetis reiterated their buy rating.

The last upgrade for Aemetis Inc happened on August 16, 2023 when UBS raised their price target to $10.5. UBS previously had a neutral for Aemetis Inc.

The last downgrade for Aemetis Inc happened on August 9, 2022 when Truist Securities changed their price target from N/A to $12 for Aemetis Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aemetis, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aemetis was filed on November 15, 2024 so you should expect the next rating to be made available sometime around November 15, 2025.

While ratings are subjective and will change, the latest Aemetis (AMTX) rating was a reiterated with a price target of $28.00 to $28.00. The current price Aemetis (AMTX) is trading at is $2.71, which is out of the analyst’s predicted range.